Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response study of intrathecal bupivacaine for cesarean section with prophylactic phenylephrine infusion
ChiCTR-IIR-17011824Phase 3Recruiting
- Sponsor
- Jiaxing Maternity and Child Health Care Hospital
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bupivacaine and phenylephrine in Conditions requiring cesarean section (2 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoint: ED50. Started Jul 2017; status: recruiting.
02
Drugs
bupivacainephenylephrine
03
Conditions
Conditions requiring cesarean section
Beyond the preview
Go deeper on ChiCTR-IIR-17011824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17011824.